New Article: Sznitman and Lewis, Cannabis in Israeli Newspaper Coverage

Sznitman, Sharon R. and Nehama Lewis. “Is Cannabis an Illicit Drug or a Medicine? A Quantitative Framing Analysis of Israeli Newspaper Coverage.” International Journal of Drug Policy 26.5 (2015): 446-52.






Various countries and states, including Israel, have recently legalized cannabis for therapeutic purposes (CTP). These changes have received mass media coverage and prompted national and international dialogue about the status of cannabis and whether or not it can be defined as a (legitimate) medicine, illicit and harmful drug, or both. News media framing may influence, and be influenced by, public opinion regarding CTP and support for CTP license provisions for patients. This study examines the framing of CTP in Israeli media coverage and the association between media coverage and trends in the provision of CTP licenses in Israel over time.


All published news articles relevant to CTP and the framing of cannabis (N = 214) from the three highest circulation newspapers in Israel were content analyzed. Articles were published between January 2007 and June 2013, a period in which CTP licenses granted by the Ministry of Health increased substantially.


In the majority of CTP news articles (69%), cannabis was framed as a medicine, although in almost one third of articles (31%) cannabis was framed as an illicit drug. The relative proportion of news items in which cannabis was framed as an illicit drug fluctuated during the study period, but was unrelated to linear or curvilinear trends in CTP licensing.


The relatively large proportion of news items framing cannabis as a medicine is consistent with growing support for the expansion of the Israel’s CTP program.



  • We examine the framing of cannabis for therapeutic purposes (CTP) in newspapers.
  • We use quantitative content analysis.
  • News articles generally describe cannabis as a medicine and not an illicit drug.
  • Trends in media framing are unrelated to trends in CTP licenses.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s